Is Eli Lilly and Company overvalued?

Eli Lilly and Company (LLY) looks overvalued — trading about 51% above its fair value.

Overvalued

Price

$1206.51

Fair value

$589.75

Current P/E

52.6

Normal P/E

25.7

Market cap

$1.14T

Dividend yield

0.6%

Return on equity

77.8%

Sector

Healthcare

Fair value compares LLY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks